A Study of AV0328 Administered to Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- PNAG-expressing Pathogenic Microbes Vaccine
- Interventions
- Biological: AV0328 - Cohort 1Biological: AV0328 - Cohort 3Biological: AV0328 - Cohort 4Biological: AV0328 - Cohort 2
- First Posted Date
- 2016-08-03
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Alopexx Vaccine, LLC
- Target Recruit Count
- 16
- Registration Number
- NCT02853617
- Locations
- 🇺🇸
Inflamax Research, Inc., Neptune, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath